Atlas Trials

Rifabutin-containing Triple Therapy for Treatment of Helicobacter Pylori

Clinical trial NCT04879992 · COMPLETED

Trial details

NCT number
NCT04879992
Sponsor
Shanghai Jiao Tong University School of Medicine
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Helicobacter Pylori Infection
Start date
2021-05-07
Primary completion
2022-10-14
Enrollment
413

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.